Everything below concerns GLP-1 receptor. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Last reviewed on 2026-07-09. Where a claim depends on a specific study, the study is described rather than over-claimed.
Retatrutide is an investigational synthetic peptide developed under the code LY3437943, with a backbone derived from glucose-dependent insulinotropic polypeptide. Several non-proteinogenic residues, including alpha-aminoisobutyric acid, appear in that backbone, and a fatty diacid side chain attached through a linker extends circulation time. The molecule carries roughly thirty-nine amino acid units and a total mass near 4.7 kilodaltons. Administration is by subcutaneous injection once weekly. Published work uses both the name retatrutide and the code LY3437943.
Pharmacologically the compound activates three receptors: GLP-1, GIP, and glucagon. GLP-1 and GIP signaling contribute to glucose-dependent insulin release, delayed gastric emptying, and reduced appetite, while glucagon receptor activation is associated with increased energy expenditure and hepatic fat oxidation. The single-molecule design is intended to keep these activities in one peptide rather than combining separate agents. Relative activity at each receptor differs, and the balance between them is a central question in interpretation. The glucagon component is partly offset by incretin-mediated insulin secretion, an interaction that remains incompletely characterized.
Pharmacologically, retatrutide acts as a triple agonist at the glucagon-like peptide-1 receptor, the glucose-dependent insulinotropic polypeptide receptor, and the glucagon receptor. Activation of the first two receptors is associated with improved insulin secretion and reduced appetite. The glucagon receptor component is thought to increase energy expenditure, a mechanism that distinguishes this molecule from dual-agonist compounds. Researchers continue to investigate how the three activities interact and whether the combined profile offers advantages that justify additional clinical testing.
Several questions about the compound remain unresolved. The durability of weight reduction after treatment stops, the frequency of gastrointestinal side effects, and the long-term cardiovascular profile are topics of ongoing study. Regulatory submissions and phase 3 trial outcomes have not been fully reported in the public literature. Because most available data come from controlled trials rather than general-population use, conclusions about effectiveness outside study settings are provisional. The distinction between established findings and open questions matters when interpreting early coverage of the drug.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide of about 39 residues | Backbone derived from a GIP sequence |
| Molecular mass | Approximately 4.7 kDa | Peptide chain plus fatty diacid moiety |
| Receptor targets | GLP-1, GIP, glucagon | Unimolecular triple agonist |
| Typical storage temperature | 2 to 8 degrees Celsius | Protect from light; avoid repeated freeze-thaw |
| Common analytical method | LC-MS/MS | Used for plasma quantification and purity checks |
Clinical development has progressed through phase 2 trials in adults with obesity and type 2 diabetes, with phase 3 programs reported as ongoing. Reported outcomes include reductions in body weight and improvements in glycemic measures over defined treatment periods. Whether these effects translate into durable benefits after treatment ends remains an open question. Long-term safety data across broad populations are not yet complete, and regulatory decisions have not been announced.
Retatrutide is an investigational synthetic peptide engineered to activate three distinct hormone receptors within a single molecule. It targets the glucose-dependent insulinotropic polypeptide receptor, the glucagon-like peptide-1 receptor, and the glucagon receptor simultaneously. This triagonist design distinguishes it from earlier incretin-based compounds that act on one or two of these pathways. Structural modifications relative to native gut hormones extend its residence time in circulation. The molecule remains under clinical evaluation and is not approved for any indication.
Receptor activation produces downstream effects that differ by tissue. GLP-1 receptor signaling influences appetite regulation and insulin secretion in a glucose-dependent manner. GIP receptor activity contributes to metabolic handling of nutrients and may modulate adipose tissue. Glucagon receptor engagement raises energy expenditure and promotes hepatic lipid turnover, though the balance among these actions in humans is still being characterized. Preclinical models showed reductions in body weight and improved glycemic markers.
开发进程从早期单次和多次给药研究推进至大规模后期试验。公开报告显示，参与者在体重和相关代谢指标上出现变化，但完整数据需经同行评审并接受独立复核。试验设计通常包括随机、双盲和对照设置，以区分药物效应与行为干预。监管提交和标签范围尚未确定；长期维持效果与心血管结局仍是开放问题。
与仅靶向单一受体的同类药物相比，瑞他鲁肽增加胰高血糖素受体成分，理论上可提高能量消耗并改变脂肪分布。临床中观察到的体重变化是否主要来自该额外机制，目前尚无定论。胃肠道反应是该类药物常见不良事件，试验中通过剂量递增和监测进行管理。停药后体重反弹、个体差异和长期耐受性仍需更多数据。
=== Medium-lived fission products === After several years of cooling, most radioactivity is from the fission products caesium-137 and strontium-90, which are each produced in about 6% of fissions, and have half-lives of about 30 years. Other fission products with similar half-lives have much lower fission product yields, lower decay energy, and several (151Sm, 155Eu, 113mCd) are also quickly destroyed by neutron capture while still in the reactor, so are not responsible for more than a tiny fraction of the radiation production at any time. Therefore, in the period from several years to several hundred years after use, radioactivity of spent fuel can be modeled simply as exponential decay of the 137Cs and 90Sr. These are sometimes known as medium-lived fission products. Krypton-85, the 3rd most active MLFP, is a noble gas which is allowed to escape during current nuclear reprocessing; however, its inertness means that it does not concentrate in the environment, but diffuses to a uniform low concentration in the atmosphere. Spent fuel in the U.S. and some other countries is not likely to be reprocessed until decades after use, and by that time most of the 85Kr will have decayed.
On 29 March, Trump stated that he would prefer to "take the oil in Iran". He proposed taking Iran's oil export center, Kharg Island, claiming that the United States could capture the territory "very easily", and implying that the US could occupy it for some time. On 30 March, Trump said that if a deal were not reached soon and the Strait of Hormuz reopened, the US would strike all of Iran's power plants, oil wells, Kharg Island, and possibly all its desalinization plants, although the feasibility and strategic value of some of Trump's threats were contested. On the same day Turkey and NATO intercepted the fourth missile directed towards Turkish territory. Iran denied firing a missile at Turkey, claiming that it was a false flag attack. The US began flying B-52 bombers over Iranian territory for the first time, indicating its confidence of air supremacy over Iran. The US used bombers to target an ammunition depot and air base in Isfahan, causing large explosions. U.S-allied Gulf states such as Saudi Arabia, the UAE, Kuwait, and Bahrain reportedly pushed Trump to continue the war until there are significant changes in Iran's leadership. American journalist Shelly Kittleson was kidnapped in Baghdad by Kata'ib Hezbollah—the strongest faction within the PMF—who demanded that the Iraqi government release several detained members of the group. On 1 April, Mehr News Agency, a semi-official Iranian government news outlet, reported that policy expert and former foreign minister Kamal Kharazi was seriously injured and his wife was killed in an airstrike which hit his home.
The leather manufacturing process is divided into three fundamental subprocesses: preparatory stages, tanning, and crusting. A further subprocess, finishing, can be added into the leather process sequence, but not all leathers receive finishing. The preparatory stages are when the hide is prepared for tanning. Preparatory stages may include soaking, hair removal, liming, deliming, bating, bleaching, and pickling. Tanning is a process that stabilizes the proteins, particularly collagen, of the raw hide to increase the thermal, chemical and microbiological stability of the hides and skins, making it suitable for a wide variety of end applications. The principal difference between raw and tanned hides is that raw hides dry out to form a hard, inflexible material that, when rewetted, will putrefy, while tanned material dries to a flexible form that does not become putrid when rewetted. Many tanning methods and materials exist. The typical process sees tanners load the hides into a drum and immerse them in a tank that contains the tanning "liquor". The hides soak while the drum slowly rotates about its axis, and the tanning liquor slowly penetrates through the full thickness of the hide. Once the process achieves even penetration, workers slowly raise the liquor's pH in a process called basification, which fixes the tanning material to the leather. The more tanning material fixed, the higher the leather's hydrothermal stability and shrinkage temperature resistance. Crusting is a process that thins and lubricates leather. It often includes a coloring operation.
=== Pathogen susceptibility === A wide range of natural pathogens can infect lab mice, often without causing overt illness but still posing a risk of altered lab results. Purposeful testing and breeding has greatly reduced the incidence. A wide range of human infectious diseases can be passed to laboratory mice, turning them into model animals for the disease for research. For diseases that do not naturally infect mice, transgenic techniques can be used to produce humanized mice expressing the requisite human genes for infection (often a cell surface receptor). A recent study detected a murine astrovirus in laboratory mice held at more than half of the US and Japanese institutes investigated. Murine astrovirus was found in nine mice strains, including NSG, NOD-SCID, NSG-3GS, C57BL6-Timp-3−/−, uPA-NOG, B6J, ICR, Bash2, and BALB/C, with various degrees of prevalence. The pathogenicity of the murine astrovirus was not known. These astroviruses were of the genus Mamastrovirus, which contains viruses that infect mammals. The course of infection in immunocompetent mice resembles that of asymptomatic astrovirus infection in immunocompetent humans, making this system a useful disease model.
Sources: en.wikipedia.org
Acupuncture practitioners should know, and be prepared to be responsible for, any substantial harm from treatments. Some acupuncture proponents argue that the long history of acupuncture suggests it is safe. However, there is an increasing literature on adverse events (e.g. spinal-cord injury). Acupuncture seems to be safe in people getting anticoagulants, assuming needles are used at the correct location and depth, but studies are required to verify these findings.
== Etymology == The English word frankincense derives from the Old French expression franc encens, meaning 'true incense', maybe with the sense of 'high quality incense'. The adjective franc in Old French meant 'noble, true', in this case perhaps 'pure'; although franc is ultimately derived from the tribal name of the Franks, it is not a direct reference to them in the word frankincense. The word for frankincense in the Koine Greek of the New Testament, λίβανος, líbanos (or λιβανωτός, libanōtós), is cognate with the name of Lebanon (Greek: Λίβανος); the same can be said with regard to Arabic, Phoenician, Hebrew, and Vulgar Latin: lĭbănus. This is postulated to be because they both derive from the word for 'white' and that the spice route went via Mount Lebanon (Koine Greek: Λίβανος, romanized: Libanos). Medieval Latin: olibanum derived from λίβανος or libanus. The leading "o" may have come from Latin: oleum, lit. 'oil', or from the Greek article o- or Arabic article al-. Other names include Arabic: اللبان, romanized: al-lubān, Persian: کندر, romanized: kondor, Syriac: בוּסמִין, romanized: busmin, Hebrew: לבונה, romanized: ləvonā, Bengali: লোবান, ধুনো, romanized: lōban, dhunō, Somali: foox (fooḥ), Turkish: akgünlük, Classical Latin: tūs.
As a consequence of widespread and injudicious use of antibacterials, there has been an accelerated emergence of antibiotic-resistant pathogens, resulting in a serious threat to global public health. The resistance problem demands that a renewed effort be made to seek antibacterial agents effective against pathogenic bacteria resistant to current antibacterials. Possible strategies towards this objective include increased sampling from diverse environments and application of metagenomics to identify bioactive compounds produced by currently unknown and uncultured microorganisms as well as the development of small-molecule libraries customized for bacterial targets.
After the war, Stalin sought to secure the Soviet Union's western border by installing communist-dominated regimes under Soviet influence in bordering countries. During and in the years immediately after the war, the Soviet Union annexed several countries as Soviet Socialist Republics within the Union of Soviet Socialist Republics. Many of these were originally countries effectively ceded to it by Nazi Germany in the Molotov–Ribbentrop Pact, before Germany invaded the Soviet Union. These later annexed territories include Eastern Poland (incorporated into two different SSRs), Latvia (became Latvia SSR), Estonia (became Estonian SSR), Lithuania (became Lithuania SSR), part of eastern Finland (Karelo-Finnish SSR and annexed into the Russian SFSR) and northern Romania (became the Moldavian SSR). In Hungary, when the Soviets installed a communist government, Mátyás Rákosi was appointed General Secretary of the Hungarian Communist Party, which began one of the harshest dictatorships in Europe under the People's Republic of Hungary. In Bulgaria, toward the end of World War II, the Soviet Union crossed the border and created the conditions for a communist coup d'état on the following night. The Soviet military commander in Sofia assumed supreme authority, and the communists whom he instructed, including Kimon Georgiev (who was not a communist himself, but a member of the elitarian political organization "Zveno", working together with the communists), took full control of domestic politics in the People's Republic of Bulgaria.
== Structure == MCH is a cyclic 19-amino acid neuropeptide, as it is a polypeptide chain that is able to act as a neurotransmitter. MCH neurons are mainly concentrated in the lateral hypothalamic area, zona incerta, and the incerto-hypothalamic area, but they are also located, in much smaller amounts, in the paramedian pontine reticular formation (PPRF), medial preoptic area, laterodorsal tegmental nucleus, and the olfactory tubercle. MCH is activated by binding to two G-coupled protein receptors (GCPRs), MCHR1 and MCHR2. MCHR2 has only been identified in certain species such as humans, dogs, ferrets, and rhesus monkeys, while other mammals such as rodents and rabbits do not have the receptor. MCH is cleaved from prepro-MCH (ppMCH), a 165 amino acid polypeptide which also contains the neuropeptides GE and EI.
Sources: en.wikipedia.org
As of the mid-2020s retatrutide remains investigational and is not an approved medicine in the United States or the European Union. It has been supplied mainly to participants in clinical trials. Labels and availability can change, so regulatory listings should be checked directly.
Dual agonists act at the GLP-1 and GIP receptors, whereas retatrutide adds glucagon receptor activity on the same peptide. This third activity is the main structural and pharmacological distinction discussed in the literature. Direct head-to-head comparisons remain limited.
Reports usually give the study code LY3437943 alongside the name, the dose in milligrams, and the week at which an endpoint was measured. Percent body-weight change is the most frequent headline measure. Units and populations vary, so comparisons across reports require care.
It is designed as a triple agonist acting on the GLP-1, GIP, and glucagon receptors. This combination is intended to influence appetite, insulin secretion, and energy expenditure. Single-receptor and dual-receptor compounds act on a narrower set of targets.